Fibroblast Growth Factor (FGF) — Skin Repair Signaling & PDRN

Fibroblast growth factors (FGFs) are a large family of structurally related signaling proteins that regulate a wide range of biological processes including cell proliferation, migration, differentiation, and survival. The FGF family comprises 22 members in humans, many of which play central roles in skin development, homeostasis, and repair . In the context of PDRN therapy and regenerative skincare, FGFs are particularly important because they are among the key mediators through which skin tissue responds to injury and initiates regeneration.

The FGF Family

The 22 known human FGFs are grouped into subfamilies based on sequence similarity and receptor binding properties :

FGF-1 (aFGF) and FGF-2 (bFGF) — The prototypical FGFs, broadly expressed and potent mitogens for fibroblasts, endothelial cells, and keratinocytes
FGF-7 (KGF) — Keratinocyte growth factor, specific to epithelial cell proliferation and wound re-epithelialization
FGF-10 (KGF-2) — Similar to FGF-7, involved in epithelial morphogenesis and repair
Endocrine FGFs (FGF-19, -21, -23) — Act as hormones regulating metabolism rather than local tissue signals

FGFs exert their effects by binding to FGF receptors (FGFRs), a family of four transmembrane receptor tyrosine kinases (FGFR1-4). Ligand binding activates downstream signaling cascades including the RAS-MAPK, PI3K-AKT, and PLC-gamma pathways, which collectively drive cell proliferation, survival, and differentiation .

FGFs in Skin Biology

Fibroblast Activation

FGF-2 is the primary mitogen for dermal fibroblasts — the cells responsible for producing collagen, elastin, and other components of the extracellular matrix. FGF-2 stimulates fibroblast proliferation, enhances collagen production, and promotes the synthesis of glycosaminoglycans that hydrate and support dermal tissue .

Wound Healing

FGFs are critical at multiple stages of wound healing :

Inflammatory phase — FGF-2 is released from damaged extracellular matrix and activated platelets, initiating the repair response
Proliferative phase — FGF-2 drives fibroblast proliferation and angiogenesis; FGF-7 stimulates keratinocyte migration and proliferation for re-epithelialization
Remodeling phase — FGFs modulate collagen turnover and matrix remodeling as the wound matures

Skin Aging

Age-related decline in FGF signaling contributes to reduced fibroblast proliferative capacity, decreased collagen synthesis, and impaired wound healing. Aged fibroblasts show diminished responsiveness to FGF stimulation, which is one mechanism underlying the progressive thinning and loss of resilience observed in aging skin.

FGF Signaling and PDRN

PDRN (polydeoxyribonucleotide) enhances the tissue environment in ways that amplify FGF-mediated repair processes :

Upregulation of Growth Factor Expression

PDRN treatment has been shown to increase the expression of multiple growth factors in treated tissues, including FGF-2. By activating the adenosine A2A receptor, PDRN triggers intracellular signaling cascades that upregulate growth factor gene transcription in fibroblasts and other dermal cells .

Fibroblast Proliferative Support

PDRN provides nucleotide building blocks through the salvage pathway, supporting the DNA synthesis demands of rapidly proliferating fibroblasts that have been activated by FGF signaling. This synergy between FGF-driven proliferative signals and PDRN-supplied nucleotide substrates enhances the overall regenerative response.

Anti-Inflammatory Optimization

FGF signaling is most effective in a balanced inflammatory environment. Excessive inflammation can degrade FGFs enzymatically and desensitize FGF receptors. PDRN's anti-inflammatory action through A2A receptor activation creates conditions in which FGF signaling operates optimally — promoting organized tissue repair rather than fibrotic scarring .

Therapeutic Applications

Tissue Regeneration

Recombinant FGFs — particularly FGF-2 and FGF-7 — have been explored clinically for accelerating wound healing and tissue regeneration. PDRN's ability to upregulate endogenous FGF production offers an alternative approach that stimulates the body's own regenerative signaling rather than relying on exogenous protein delivery .

Skin Rejuvenation

In aesthetic dermatology, treatments that enhance FGF signaling — including PDRN injections — support dermal remodeling by stimulating fibroblast activity. This results in improved collagen density, dermal thickness, and overall skin quality.

Combination Strategies

PDRN-based therapies and FGF-rich preparations (such as platelet-rich plasma) are sometimes used in combination. The rationale is that PDRN enhances the cellular environment and provides proliferative support, while exogenous growth factors including FGFs provide direct mitogenic stimulation.

Growth Factors — The broader family of signaling proteins that includes FGFs
Fibroblast — The primary target cell of FGF signaling in the dermis
Collagen Synthesis — A downstream outcome of FGF-stimulated fibroblast activity
Wound Healing — The clinical process most dependent on FGF signaling
Cell Proliferation — The cellular process driven by FGF-FGFR activation